Anima Biotech

📣 PARTNERSHIP 📣 We are proud to announce our collaboration with AbbVie to discover and develop mRNA biology modulators for three targets across oncology and immunology using Anima’s mRNA Lightning platform. We are looking forward to joining forces and kicking off the collaboration. Congrats to the teams ✨. Press release>> http://bit.ly/3ICBXEh

🚨Happening TODAY: Genetic Engineering & Biotechnology News’s Inaugural Virtual Summit - “The State of AI in Drug Discovery”! Join Generoso Ianniciello, Chief Business Officer at Anima Biotech, to explore how #VisualBiology is reshaping the way we understand diseases and discover drugs. Discover how we leverage #LightningAI, our #TechBio #VisualBiology platform to train, evolve, and exploit Disease AI Models, transforming the discovery of novel targets and delivering better drug candidates. 🔍 Session Spotlight: We will present #Lightning.AI, showcasing how neural networks trained on large-scale pathway imaging data from healthy and diseases cells recognize dysregulated pathways. Generoso Ianniciello will present how the platform identifies novel targets, delivers better drug candidates and share key breakthroughs from our IPF and ALS programs. When: Today at 8:00 AM PST / 11:00 AM EST 🎯 Where: GEN Virtual Summit 🎯 Why Attend: Hear from us and other key leaders on the latest advances in AI-powered drug discovery, including Nobel Laureate David Baker (Institute for Protein Design, University of Washington), 💥 Don’t miss out on this FREE event! Register now to explore the latest in AI-powered drug discovery: To register for free, visit: https://lnkd.in/gnGGAK_r

Excited to announce that Anima Biotech will be participating in the State of AI in Drug Discovery 2024 Summit, hosted by Genetic Engineering & Biotechnology News Our CBO, Generoso Ianniciello, will present how we are transforming Target and Drug Discovery with Visual Biology-driven AI disease models, leveraging our TechBio Platform , #Lightning.AI Join us Wednesday 30th October at 08:50 EDT. Register here: https://lnkd.in/gh8U2Zcb #AIinDrugDiscovery #AnimaBiotech #LightningAI #TechBio #StateofAI

It’s happening today! 🎉 Join us for the LightON mRNA Masterclass, in partnership with Endpoints News, where you’ll hear from: 🎙️ Vladislav Kim, Machine Learning Researcher at Bayer 🎙️ Inbal Shapira Lots, Head of Data Analysis at Anima Biotech They’ll delve into how cutting-edge AI, combined with high-content cellular morphology and pathway visualization, is uncovering disease mechanisms, identifying novel targets, and discovering potential drugs by analyzing millions of images from patient-derived cells.🧬🔍 Don’t miss out—register now! https://lnkd.in/d4Wt5GWx #drugdiscovery #noveltargets #AI #ML #LightningAI #TechBio

Just one day to go – Tomorrow, October 15th! In partnership with Endpoints News, join us for the LightON mRNA Masterclass featuring: 🎙️ Vladislav Kim, Machine Learning Researcher at Bayer, and 🎙️ Inbal Shapira Lots, Head of Data Analysis at Anima Biotech. They’ll dive into how AI-driven cellular microscopy is unlocking disease mechanisms, paving the way for novel target identification and groundbreaking drug discovery! 🧬🔍 Don’t miss this exciting session—register now! https://lnkd.in/d4Wt5GWx #drugdiscovery #noveltargets #AI #ML

📅 Save the date – October 15th! In partnership with Endpoints News, join the LightON mRNA Masterclass featuring: 🎙️ Vladislav Kim, Machine Learning Researcher at Bayer, and 🎙️ Inbal Shapira Lots, Head of Data Analysis at Anima Biotech, They will showcase the power of AI-driven cellular microscopy imaging in recognizing disease mechanisms for novel target identification and drug discovery! 🧬🔍 Don't miss this exciting session—register now! https://lnkd.in/d4Wt5GWx #drugdiscovery #noveltargets #AI #ML

📢 Join Generoso Ianniciello at the Drug Discovery on Target breakout session "Challenges and Opportunities in Pursuing RNA as a Drug Target". Panel discussion will cover topics on probing and modulating RNA, small molecules targeting RNA, and AI/ML and RNA degradation tools in drug development. Don't miss it! #DrugDiscovery #Biotech #RNA #AI #ML

Join Generoso Ianniciello, Chief Business Officer at Anima Biotech, as he presents at Discovery on Target 🎯 His presentation, titled "Visual Biology Drug Discovery," will showcase how Anima's pioneering Lightning AI platform generates new disease data by imaging cellular pathways through large-scale experimental biology🧬💊 📅 Don’t miss this insightful presentation, Boston, October 1st, 1:50PM.

🔬 Analyzing mRNA localization in response to stimuli provides key insights into protein amount changes at the endpoint. By visualizing 🔎 how mRNA is localized within cells, we gain essential understanding of gene expression regulation and cellular function🧬🧫. This exclusive insight is pivotal in enhancing disease treatment through the development of innovative mRNA-based drugs and vaccines✨. #mRNALocalization #mRNAregulation #drugdiscovery #mRNA

Anima continues to grow 🌱 and with that we welcome many new faces! Welcoming Adi Amar-Schwartz, Nitsan Elmalam, Claudia Maggi, Shaked Bergman, and Yuliya Momotov to the Anima team 🥂🎉. Together we continue to advance our mRNA Lightning® platform across therapeutic areas in the discovery of mRNA small molecules, targets, and RNA-based drug and vaccine optimization🧬🔬. Wishing you all the best in your new roles! 👨🔬👩🔬👨🔬 #WelcometoAnima #mRNAbiology #Hiring #TeamExpansion #mRNA